SOLACI-CACI 2021 | SAC-FAC Session

✔️ Watch again the complete SAC-FAC Session in the SOLACI-CACI 2021 Congress.

👨‍🏫 Program:

– SESSION I: Functional Mitral Regurgitation: New Horizons for Transcatheter Therapy

  • 01:06 – Optimal Medical Treatment in Patients with Cardiac Failure and Mitral Regurgitation – Florencia Renedo
  • 12:12 – Ultrasonographic Screening of Patients for Endovascular Therapy – Walter García
  • 25:43 – Mitral Valve Percutaneous Repair. Evidence. An Interventional Cardiologist’s Perspective – Jaime Fonseca

👉🏻 Chairpersons: Session I: Eduardo Perna
👉🏻 Panelists: Agüero, Marcelo – Cursack, Guillermo – Fernández Murga, Arturo – Garófalo, Pablo – Larribau, Miguel – Vigo, Santiago José

SESSION II: Medical Treatment and Revascularization in Patients with Chronic Coronary Syndrome

  • 53:09 – Optimal Medical Treatment – Juan Muntaner
  • 01:04:44 – Non-Invasive Diagnostic Methods – Roxana Campisi
  • 01:16:10 – Endovascular Revascularization – Daniel Berrocal

👉🏻 Chairpersons: Session II: Alejandro Hershson & Alejandro Machaín
👉🏻 Panelists: Comtesse, Daniel – Higa, Claudio – Moreyra, Eduardo – Navarro Estrada, José Luis – Pérez Baliño, Pablo – Tajer, Carlos – Swieszkowski, Sandra


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...